Skip to main content


You are viewing the new article page. Let us know what you think. Return to old version

Poster presentation | Open | Published:

Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis

The aim of our study was to prospectively evaluate bone density in adolescents females with JIA, and to correlate the results with puberty. Lumbar spine (L2–L4) areal bone mineral density (aBMD) (assessed by Dual X-ray Absorbiometry, DXA) was monitored every 6–12 months in a group of 38 girls with JIA. The evaluated bone density accrual during the peripubertal time as well as absolute and relative (Z-score) aBMD in relationship with age at menarche, JIA subset, disease activity, corticosteroid and methotrexate treatment was assessed. Height, body mass index, Bone Mass Content values were also collected. Volumetric BMD evaluated with a geometric correction formula has been calculated and compared to aBMD.

Patients were divided into two groups:

- group I included girls with menarche age within normal limits for italian standards;

- group II included girls with delayed menarche. The BMD values and Z scores in group I were not significantly different to normal population. The BMD values and Z scores in group II were significantly decreased when compared to the normal population (p < 0.001). With a multivariate analysis only age at menarche seemed independently related to peripubertal mineralization (p = 0.025, r between -0.65 and -0.75). With a binary logistic analysis only disease activity (ESR and Hgb values) seems independently related to a menarche delay (1.24 ± 0.4 for each mm/h). Our data show a critical role for disease activity in determination of a regular pubertal onset and an optimal bone density achievement.

Author information

Correspondence to A Lurati.

Rights and permissions

Reprints and Permissions

About this article


  • Bone Mineral Density
  • Methotrexate
  • Bone Density
  • Juvenile Idiopathic Arthritis
  • Adolescent Female